GSK »

Ideaya Biosciences shares owned by GSK

Quarter-by-quarter ownership of Ideaya Biosciences (IDYA) shares owned by GSK from 13F filings

Historical chart of GSK investment in Ideaya Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Ideaya Biosciences held by GSK consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ideaya Biosciences by GSK

Quarter filed Position value Share count Share price at filing
2026-06-30 $50M 1.3M 37.27

More positions owned by GSK

Crispr Therapeutics Namen Akt (CRSP)
Wave Life Sciences SHS (WVE)
Vir Biotechnology (VIR)
Biontech Se Sponsored Ads (BNTX)
Ideaya Biosciences (IDYA)
Cytokinetics Com New (CYTK)
Lyell Immunopharma Com New (LYEL)
Spero Therapeutics (SPRO)
Nkarta (NKTX)
Fulcrum Therapeutics (FULC)
Bicycle Therapeutics Sponsored Ads (BCYC)
CVRX (CVRX)
Regenxbio Inc equity us cm (RGNX)

View all positions for GSK

Top funds holding Ideaya Biosciences

FMR
BlackRock
Henderson Group
Capital Research Global Investors
Baker Bros. Advisors
State Street Corporation
Vanguard Capital Management
Logos Global Management
Adage Capital Partners GP
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Dimensional Fund Advisors
Deerfield Management Company
Fiera Capital Corporation

View all funds holding Ideaya Biosciences